← Leaderboards
Andrew Serghios Barbas
Duke University
$3,383,335
Attributed
$8,085,272
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,085,272 · 6
By mechanism
R44$3,527,840 · 1
U01$1,903,303 · 1
R01$1,621,762 · 1
U19$520,309 · 2
K08$512,058 · 1
Top collaborators
- Aravind Asokan4 shared
- Todd Victor Brennan4 shared
- Allan D. Kirk4 shared
- Justin Joseph Pollara4 shared
- Robert Neusner2 shared
- Prabir Roy-Chaudhury2 shared
Most similar at Duke University
Same institution · by research overlap
- Alejandro Aballay$11,930,620
- Staci D Bilbo$12,627,005
- Pamela Susan Douglas$66,022,992
- Donald T. Fox$5,009,082
- Matthias Gromeier$11,871,021
Others in their field
Other Emerging Leaders on “Transplantation”
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$32,078,740
- Bronwen Shaw · Medical College Of Wisconsin$24,584,971
- Greg Westergaard · Alpha Genesis Inc$18,927,907
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$13,580,468
- Raghuveera Yaramolu · Eminent Services Corporation$9,791,923
- Kirsten Johansen · Hennepin Healthcare Research Institute$9,776,955
Research focus
TransplantationInjuryGraft FunctionOrganPost-TransplantPerfusionResearch PersonnelAllograftingCellsUnited StatesRattusLiver TransplantationExperimental StudyMediatingOrgan DonorHeart TransplantationKidneyGraft SurvivalOrgan TransplantationTransplant ModelHigh RiskDesignClinical TrialsKidney Transplantation
Grant awards (16)
Platform for Extended Kidney Preservation Via Subnormothermic Perfusion$1,657,705
R44 · FY2025 · DK
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors$469,775
U01 · FY2025 · AI · contact PI
Administrative Core$166,644
U19 · FY2025 · AI · contact PI
Platform for Extended Kidney Preservation Via Subnormothermic Perfusion$1,870,135
R44 · FY2024 · DK
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors$473,435
U01 · FY2024 · AI · contact PI
Administrative Core$177,892
U19 · FY2024 · AI · contact PI
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors$477,093
U01 · FY2023 · AI · contact PI
Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patterns$403,171
R01 · FY2023 · AI
Administrative Core$175,773
U19 · FY2023 · AI · contact PI
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors$483,000
U01 · FY2022 · AI · contact PI
Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patterns$403,163
R01 · FY2022 · AI
Therapeutic strategies to improve function of high risk liver grafts$136,650
K08 · FY2022 · AI · contact PI
Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patterns$407,815
R01 · FY2021 · AI
Therapeutic strategies to improve function of high risk liver grafts$187,704
K08 · FY2021 · AI · contact PI
Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patterns$407,613
R01 · FY2020 · AI
Therapeutic strategies to improve function of high risk liver grafts$187,704
K08 · FY2020 · AI · contact PI